RAF1 and lung carcinoma: The present study tests a novel noncompetitive, non-polyamine-based polyamine transport inhibitor and small molecule inhibitor of RAF, GW5074, which has been shown to be effective in diverse studies, including mediating neuroprotection and alleviating epithelial to mesenchymal transition in a preclinical lung cancer model [28,29].